Diagnosis of CARASIL involves a combination of clinical performance, imaging, laboratory testing, and pathology. The platform can help connect a team of authoritative experts at home and abroad to provide accurate diagnostics and treatment programs. Treatment and management of CARASIL treatments require the development of a multi-dimensional approach, typically including pharmacotherapy, rehabilitation interventions, and regular follow-up.
In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many neurological diseases that have been difficult to treat have been significantly improved. Treatment requires close monitoring of efficacy and adverse reactions and timely adjustment according to changes in disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of CARASIL.
The platform serves a team of nationally and internationally authoritative experts in the field of neural systems aligned with the International Medical Service System of China, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.